Close Menu

Moody's

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday. The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it is buying One Lambda for $925 million, ratings agency Moody's Investors Service downgraded the company's s

NEW YORK (GenomeWeb News) – Moody's Investors Service has upgraded $2.3 billion of Life Technologies' Senior Unsecured Notes to investment grade from speculative grade.

Earlier this month the California Institute for Regenerative Medicine said it plans to privately sell $200 million in bonds in this and the following fiscal year in case it will be unable to access public capital.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.